China Pharma Holdings EPS - Earnings per Share 2010-2023 | CPHI
China Pharma Holdings eps - earnings per share from 2010 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| China Pharma Holdings Annual EPS |
| 2023 |
$-0.91 |
| 2022 |
$-3.78 |
| 2021 |
$-3.70 |
| 2020 |
$-3.50 |
| 2019 |
$-24.00 |
| 2018 |
$-12.50 |
| 2017 |
$-22.00 |
| 2016 |
$-10.50 |
| 2015 |
$-17.50 |
| 2014 |
$-45.50 |
| 2013 |
$-23.00 |
| 2012 |
$5.50 |
| 2011 |
$22.00 |
| 2010 |
$27.00 |
| 2009 |
$21.50 |
| China Pharma Holdings Quarterly EPS |
| 2023-09-30 |
$-0.30 |
| 2023-06-30 |
$-0.30 |
| 2023-03-31 |
$-0.30 |
| 2022-12-31 |
$-1.00 |
| 2022-09-30 |
$-0.80 |
| 2022-06-30 |
$-0.90 |
| 2022-03-31 |
$-1.10 |
| 2021-12-31 |
$-0.70 |
| 2021-09-30 |
$-1.00 |
| 2021-06-30 |
$-1.00 |
| 2021-03-31 |
$-1.00 |
| 2020-12-31 |
$-1.50 |
| 2020-09-30 |
$-1.00 |
| 2020-06-30 |
$0.00 |
| 2020-03-31 |
$-1.00 |
| 2019-12-31 |
$-21.50 |
| 2019-09-30 |
$-1.00 |
| 2019-06-30 |
$-1.00 |
| 2019-03-31 |
$-0.50 |
| 2018-12-31 |
$-9.00 |
| 2018-09-30 |
$-2.00 |
| 2018-06-30 |
$-1.00 |
| 2018-03-31 |
$-0.50 |
| 2017-12-31 |
$-16.00 |
| 2017-09-30 |
$-2.50 |
| 2017-06-30 |
$-2.50 |
| 2017-03-31 |
$-1.00 |
| 2016-12-31 |
$-3.50 |
| 2016-09-30 |
$-2.00 |
| 2016-06-30 |
$-3.00 |
| 2016-03-31 |
$-2.00 |
| 2015-12-31 |
$-18.00 |
| 2015-09-30 |
$3.50 |
| 2015-06-30 |
$1.50 |
| 2015-03-31 |
$-4.50 |
| 2014-12-31 |
$-25.50 |
| 2014-09-30 |
$-7.50 |
| 2014-06-30 |
$-10.00 |
| 2014-03-31 |
$-2.50 |
| 2013-12-31 |
$-12.50 |
| 2013-09-30 |
$-2.50 |
| 2013-06-30 |
$-5.00 |
| 2013-03-31 |
$-3.00 |
| 2012-12-31 |
$-1.00 |
| 2012-09-30 |
$1.50 |
| 2012-06-30 |
$2.00 |
| 2012-03-31 |
$3.00 |
| 2011-12-31 |
$4.50 |
| 2011-09-30 |
$5.50 |
| 2011-06-30 |
$6.00 |
| 2011-03-31 |
$6.00 |
| 2010-12-31 |
$7.50 |
| 2010-09-30 |
$7.00 |
| 2010-06-30 |
$7.00 |
| 2010-03-31 |
$5.50 |
| 2009-12-31 |
$3.50 |
| 2009-09-30 |
$8.50 |
| 2009-06-30 |
$5.00 |
| 2009-03-31 |
$4.50 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.005B |
$0.007B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
